Europe Electrosurgery Market

The Europe electrosurgery market is projected to reach USD 3.31 billion by 2031 from USD 2.42 billion in 2025, at a CAGR of 5.3% during the forecast period.

The Europe electrosurgery market is influenced by factors such as the increasing number of surgeries associated with aging, the rising incidence of lifestyle diseases, and the growing trend of obesity, which in turn necessitate the use of energy-based surgical interventions. The continuous launch of new electrosurgical products contributes significantly to the quick adoption of the technology in hospitals and surgical centers. Moreover, the growing knowledge and uptake of bariatric and cosmetic surgeries, which depend mainly on the use of minimally invasive techniques facilitated by electrosurgical systems, present a considerable potential for market expansion.

To know about the assumptions considered for the study download the pdf brochure

Some of the prominent players operating in the market include Medtronic (Ireland), Baxter (US), Johnson & Johnson (US),  B Braun SE (Germany), Erbe Elektromedizin GmbH (Germany), Olympus Corporation (Japan), BOWA-electronic GmbH & Co. KG (Germany), Conmed Corporation (US), and other players. The? key players in the Europe electrosurgery market actively maintain their competitive position through continuous innovation, expansion to new regions, and strategic collaborations. Companies are increasing their R&D spending to create more ergonomically and technologically advanced electrosurgical systems that ensure safety and efficiency. To spread their presence all over Europe, the players in the market are actively looking for partnerships and acquisitions, which help them to diversify the product portfolio and have access to the new healthcare systems. Various companies are also using organic strategies, like launching products and getting approvals from regulatory authorities such as the EMA and national health agencies.

In October 2025, Olympus Corporation announced the launch of THUNDERBEAT II, its next-generation hybrid energy device designed for advanced soft-tissue management across Europe, the Middle East, andOfrica (EMEA).

In April 2025, Erbe Elektromedizin GmbH introduced its next-generation tailored electrosurgical generators designed to optimize high-performance surgical workflows. The launch features VIO® 3n and VIO® seal, two advanced systems that elevate electrosurgical precision, efficiency, and procedural safety.

In February 2025, BOWA MEDICAL UK announced a key milestone in the development of its new headquarters in Kingskerswell, signaling progress in the company's long-term expansion strategy. The upcoming facility is expected to substantially strengthen BOWA's operational capacity and enable the company to better address the rising demand for its electrosurgical products across the UK market.

In May 2024, Erbe Elektromedizin GmbH inaugurated a state-of-the-art production and development facility in Rangendingen, near Tübingen, Germany. The 25,000 m² plant significantly enhances the company's global manufacturing capacity for advanced medical technology instruments.

Medtronic (Ireland)

Medtronic is a key player in the Europe electrosurgery market. It runs its business through several well-established subsidiaries in Europe. Medtronic's network of subsidiaries includes Advanced Medical Technologies GmbH (Germany), Covidien Adhesives Italia Srl (Italy), Covidien Swiss Holdings GmbH (Switzerland), Mallinckrodt DAR Srl (Italy), Medtronic France (France), and Medtronic GmbH (Germany). This network of subsidiaries enables the company to serve hospitals, clinics, and surgical centers across the region efficiently. Moreover, Medtronic offers a broad range of electrosurgical products in the market. Some of these products are the Valleylab energy platform, advanced generators, smoke-evacuation systems, and various surgical procedure-supporting accessories. The company is also involved in research & development. It invested USD 2,732 million in the fiscal year 2024. This expenditure empowers the company to be able to launch next-generation products that are customized to the surgical needs of Europe, which are constantly changing. These factors put Medtronic in a very strong position among the top players in the Europe electrosurgery ?‍?‌‍?‍‌?‍?‌‍?‍‌market.

Johnson & Johnson (US)

Johnson & Johnson is a key player in the Europe electrosurgery market. It has a strong local presence, an extensive product range, and a continuous innovations ethos. The company offers an entire range of cutting, coagulation, and neutral electrodes, generators, accessories, and smoke-extraction systems for open and minimally invasive surgeries through its Ethicon division.  There are several subsidiaries of the company in different parts of Europe. Some of the subsidiaries are Cilag AG (Switzerland), Cordis (France), DePuy Orthopadie GmbH (Germany), Johnson & Johnson GmbH (Germany), Johnson & Johnson Limited (UK), and Johnson & Johnson Medical NV (Belgium). This allows the company to serve hospitals efficiently and understand country-specific clinical needs. The company is committed to investing in R&D. For instance, it spent USD 17.2 billion in 2024. Such expenditures fuel the innovation of advanced products like the DUALTO™ Energy System launched in 2025. These factors have positioned Johnson & Johnson as one of the key players in the Europe electrosurgery market.

Market Ranking

The Europe electrosurgery market is highly consolidated, with five key players, Medtronic (Ireland), Johnson & Johnson (US), Olympus Corporation (Japan), B Braun SE (Germany), and Conmed Corporation (US), collectively holding a share of >50% of the Europe electrosurgery market. Medtronic (Ireland)  growth is supported by its extensive product portfolio and strong worldwide presence, which drives high adoption across healthcare settings. Johnson & Johnson (US) leverages its huge portfolio of electrosurgery products, which are further strengthened by the company's established hospital network. Olympus Corporation (Japan) secures a strong position through continuous investments in advanced electrosurgical generators and smoke evacuation systems, enabling steady product innovation. B Braun SE (Germany) offers various electrosurgical products across European countries. Conmed Corporation (US) also contributes to market growth by offering a diverse range of electrosurgery products that cater to hospitals, clinics, and other end users.

Related Reports:

Europe Electrosurgery Market by Product (Instruments, Accessories, Generators, Smoke Evacuation Systems), Surgery (Cardiovascular, Orthopedic, Cosmetic, Oncology, Urology), End User (Hospitals, Ambulatory Surgical Centers) - Regional Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com